More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Mouse anti BrdU (bromodeoxyuridine)

Mouse anti BrdU (bromodeoxyuridine)

Research Use Only
X1028
Nordic-MUbio
ApplicationsFlow Cytometry, Western Blot, ImmunoHistoChemistry
Product group Antibodies
Price on request
100 ug
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    Nordic-MUbio
  • Product Name
    Mouse anti BrdU (bromodeoxyuridine)
  • Delivery Days Customer
    7
  • Application Supplier Note
    Reacts with cells containing incorporated BrdU, showing a clear, nucleus confined, speckled pattern. Optimal concentration should be evaluated by serial dilutions. Applications: Flow Cytometry Staining, Immuohistochemistry.
  • Applications
    Flow Cytometry, Western Blot, ImmunoHistoChemistry
  • Applications Supplier
    Flow Cytometry;Immunohistochemistry
  • Category Supplier
    Primary antibodies
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    MoBU
  • Conjugate
    Unconjugated
  • Host
    Mouse
  • Isotype
    IgG1
  • Scientific Description
    Anti-Bromodeoxyuridine Mouse MoBU Monoclonal Antibody
  • Shelf life instruction
    See expiration date on vial
  • Reactivity Supplier Note
    Bromodeoxyuridine conjugated to Helix Pomatia Haemocyanin used to immunize BALB/c mice
  • UNSPSC
    12352203

References

  • 1. Nakamura, S., et al. Application of bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody for the in vivo analysis of proliferative characteristics of human leukemia cells in bone marrows. Oncology 1991, 48, 285-289 2. Wilson, G., Cell kinetic studies using a monoclonal antibody to bromodeoxyuridine. Methods Mol. Biol. 1998, 80, 255-266 3. Gray, J. (Ed), Special Issue: Monoclonal antibodies against bromodeoxyuridine Cytometry 1985, Vol. 6(6) 4. Gutschalk, C.M., et al. ‘Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor Promote Malignant Growth of Cells from Head and Neck Squamous Cell Carcinomas In vivo.’ Cancer Res., 66, 8026-8036 (2006).